Patents by Inventor Ingeborg van Leeuwen

Ingeborg van Leeuwen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydroindazoles and medical uses thereof
    Patent number: 11795157
    Abstract: There is herein provided a compound of formula I or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: October 24, 2023
    Inventors: Sonia Lain, Catherine Drummond, Ingeborg Van Leeuwen, Martin Haraldsson, Lars Johansson, Lars Sandberg, Ulrika Yngve
  • TETRAHYDROINDAZOLES AND MEDICAL USES THEREOF
    Publication number: 20210230141
    Abstract: There is herein provided a compound of formula I or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.
    Type: Application
    Filed: January 8, 2021
    Publication date: July 29, 2021
    Inventors: Sonia Lain, Catherine Drummond, Ingeborg Van Leeuwen, Martin Haraldsson, Lars Johansson, Lars Sandberg, Ulrika Yngve
  • Tetrahydroindazoles and medical uses thereof
    Patent number: 10889564
    Abstract: There is herein provided a compound of formula I (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.
    Type: Grant
    Filed: November 1, 2016
    Date of Patent: January 12, 2021
    Assignee: Genase Therapeutics B.V.
    Inventors: Sonia Lain, Catherine Drummond, Ingeborg Van Leeuwen, Martin Haraldsson, Lars Johansson, Lars Sandberg, Ulrika Yngve
  • TETRAHYDROINDAZOLES AND MEDICAL USES THEREOF
    Publication number: 20190152943
    Abstract: There is herein provided a compound of formula I (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.
    Type: Application
    Filed: November 11, 2016
    Publication date: May 23, 2019
    Inventors: Sonia Lain, Catherine Drummond, Ingeborg van Leeuwen, Martin Haraldsson, Lars Johansson, Lars Sandberg, Ulrika Yngve